149 related articles for article (PubMed ID: 23200181)
21. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
[TBL] [Abstract][Full Text] [Related]
22. Effect of hematoporphyrin monomethyl ether-sonodynamic therapy (HMME-SDT) on hypertrophic scarring.
Zhang H; Liu X; Liu Y; Wu Y; Li H; Zhao C; Li H; Meng Q; Li W
PLoS One; 2014; 9(1):e86003. PubMed ID: 24465834
[TBL] [Abstract][Full Text] [Related]
23. Hematoporphyrin monomethyl ether mediated photodynamic therapy inhibits oral squamous cell carcinoma by regulating the P53-miR-21-PDCD4 axis via singlet oxygen.
Meng P; Sun Y; Li E; Liu Y; Wang C; Song L
Lasers Med Sci; 2022 Aug; 37(6):1-9. PubMed ID: 35260928
[TBL] [Abstract][Full Text] [Related]
24. Low-Intensity Ultrasound Combined with Hematoporphyrin Monomethyl Ether in the Treatment of Experimental Periodontitis in Rats.
Zhuang D; Ji Z; Bi L; Wang X; Zhou Q; Cao W
Biomed Res Int; 2016; 2016():7156716. PubMed ID: 27975058
[No Abstract] [Full Text] [Related]
25. Hematoporphyrin monomethyl ether-mediated photodynamic therapy inhibits the growth of keloid graft by promoting fibroblast apoptosis and reducing vessel formation.
Cui X; Zhu J; Wu X; Yang S; Yao X; Zhu W; Xu P; Chen X
Photochem Photobiol Sci; 2020 Jan; 19(1):114-125. PubMed ID: 31934700
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic inactivation of Candida albicans by hematoporphyrin monomethyl ether.
Liu C; Hu M; Zeng X; Nair SP; Xu J
Future Microbiol; 2016; 11(3):351-62. PubMed ID: 26933758
[TBL] [Abstract][Full Text] [Related]
27. Differences in sensitivity to HMME-mediated photodynamic therapy between EBV+ C666-1 and EBV- CNE2 cells.
Li B; Chen Z; Liu L; Huang Z; Huang Z; Xie S
Photodiagnosis Photodyn Ther; 2010 Sep; 7(3):204-9. PubMed ID: 20728846
[TBL] [Abstract][Full Text] [Related]
28. Hematoporphyrin monomethyl ether-mediated photodynamic therapy selectively kills sarcomas by inducing apoptosis.
Zeng H; Sun M; Zhou C; Yin F; Wang Z; Hua Y; Cai Z
PLoS One; 2013; 8(10):e77727. PubMed ID: 24204937
[TBL] [Abstract][Full Text] [Related]
29. Effect of hematoporphyrin monomethyl ether-mediated PDT on the mitochondria of canine breast cancer cells.
Li HT; Song XY; Yang C; Li Q; Tang D; Tian WR; Liu Y
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):414-21. PubMed ID: 24284094
[TBL] [Abstract][Full Text] [Related]
30. Hematoporphyrin monomethyl ether enhances the killing action of ultrasound on osteosarcoma in vivo.
Tian Z; Quan X; Xu C; Dan L; Guo H; Leung W
J Ultrasound Med; 2009 Dec; 28(12):1695-702. PubMed ID: 19933484
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939.
Wang JB; Liu LX; Pan SH; Wang CY; Fu QF
Neoplasma; 2010; 57(1):79-85. PubMed ID: 19895177
[TBL] [Abstract][Full Text] [Related]
32. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation.
Ding X; Xu Q; Liu F; Zhou P; Gu Y; Zeng J; An J; Dai W; Li X
Cancer Lett; 2004 Dec; 216(1):43-54. PubMed ID: 15500948
[TBL] [Abstract][Full Text] [Related]
33. Effects of photodynamic therapy using hematoporphyrin monomethyl ether on experimental choroidal neovascularization.
Fan S; Qiu H; Huang H; Gu Y; Zeng J
Photochem Photobiol; 2010; 86(4):972-80. PubMed ID: 20553408
[TBL] [Abstract][Full Text] [Related]
34. HematoPorphyrin Monomethyl Ether polymer contrast agent for ultrasound/photoacoustic dual-modality imaging-guided synergistic high intensity focused ultrasound (HIFU) therapy.
Yan S; Lu M; Ding X; Chen F; He X; Xu C; Zhou H; Wang Q; Hao L; Zou J
Sci Rep; 2016 Aug; 6():31833. PubMed ID: 27535093
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal effects of hematoporphyrin monomethyl ether-mediated photosensitization against pathogenic communities from supragingival plaque.
Sun Y; Xing D; Shen L; Sun M; Fang M; Bi L; Sui Y; Zhang Z; Cao W
Appl Microbiol Biotechnol; 2013 Jun; 97(11):5079-87. PubMed ID: 23615742
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death.
Kim HS; Lee YS; Kim DK
Pharmacology; 2009; 84(5):300-9. PubMed ID: 19829019
[TBL] [Abstract][Full Text] [Related]
37. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
38. Yolk-structured multifunctional up-conversion nanoparticles for synergistic photodynamic-sonodynamic antibacterial resistance therapy.
Xu F; Hu M; Liu C; Choi SK
Biomater Sci; 2017 Mar; 5(4):678-685. PubMed ID: 28280817
[TBL] [Abstract][Full Text] [Related]
39. Ultrasound-triggered breast tumor sonodynamic therapy through hematoporphyrin monomethyl ether-loaded liposome.
Zhang Y; Ou Y; Guo J; Huang X
J Biomed Mater Res B Appl Biomater; 2020 Apr; 108(3):948-957. PubMed ID: 31389180
[TBL] [Abstract][Full Text] [Related]
40. A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes.
Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Jiang X
Nanotechnology; 2011 Jul; 22(26):265105. PubMed ID: 21586819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
